Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

196
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline plc : Director/PDMR Shareholding

05/03/2012 | 02:11pm US/Eastern

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
React to this article
Latest news on GLAXOSMITHKLINE PLC
12:10p GLAXOSMITHKLINE : Britain to offer all infants meningitis B vaccine
01:56a GLAXOSMITHKLINE : UK Department of Health Reports on 2 Proposed Ebola Vaccines
03/28 GLAXOSMITHKLINE : GSK statement on meningitis vaccination in the UK
03/27 GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
03/27 GLAXOSMITHKLINE : GSK receives approval for Encruse Ellipta in Japan for the tre..
03/27 GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
03/26 AstraZeneca, Glaxo Sign Up For 100,000 Genomes Project Consortium
03/26 NOVARTIS : BUSINESS INSIDE CHRONICLE BATH Family's greatest hope yet in the figh..
03/26 GLAXOSMITHKLINE : Glaxo Gets Approval For Encruse Ellipta, Two Other Products In..
03/26 GLAXOSMITHKLINE : GSK receives approval for Encruse® Ellipta® in Japan for the t..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF